OWC Pharmaceutical Research (OWC Pharmaceutical Research) Net Change in Cash : $-2.75 Mil (TTM As of Sep. 2019)

View and export this data going back to 2008. Start your Free Trial

What is OWC Pharmaceutical Research Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

OWC Pharmaceutical Research's Net Change in Cash for the three months ended in Sep. 2019 was $-0.38 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Sep. 2019 was $-2.75 Mil.

OWC Pharmaceutical Research Net Change in Cash Historical Data

The historical data trend for OWC Pharmaceutical Research's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OWC Pharmaceutical Research Net Change in Cash Chart

OWC Pharmaceutical Research Annual Data

Trend

Dec08

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Net Change in Cash

Get a 7-Day Free Trial

1.47

-1.11

0.12

0.50

2.49

OWC Pharmaceutical Research Quarterly Data
	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19
Net Change in Cash	Get a 7-Day Free Trial															-0.43	-0.75	-0.66	-0.96	-0.38

OWC Pharmaceutical Research Net Change in Cash Calculation

OWC Pharmaceutical Research's Net Change in Cash for the fiscal year that ended in Dec. 2018 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	-2.499	+	-0.028	+	5.023	+	-0.003
	=	2.49

OWC Pharmaceutical Research's Net Change in Cash for the quarter that ended in Sep. 2019

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= -0.372 + 0 + 0 + -0.003

= -0.38

Net Change in Cash for the trailing twelve months (TTM) ended in Sep. 2019 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.75 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OWC Pharmaceutical Research Net Change in Cash Related Terms
Thank you for viewing the detailed overview of OWC Pharmaceutical Research's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

OWC Pharmaceutical Research (OWC Pharmaceutical Research) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » OWC Pharmaceutical Research Corp (OTCPK:OWCP) » Definitions » Net Change in Cash

Comparable Companies

PARNF CANB CXUS APPB MYHI CNABQ PCYN BSPK LITH GSRX ZTS TSE:4502 XTER:MRK HKSE:03692 TSE:4523 SZSE:000661 TSE:4507 SZSE:000538 NSE:SUNPHARMA SZSE:300601

Traded in Other Exchanges

N/A

Address

2 Ben Gurion Street, Ramat Gan, ISR, 5257334

Website

http://www.owcpharma.com

OWC Pharmaceutical Research Corp is a medical cannabis research and development company. The firm through its subsidiary researches and develops cannabis-based products and treatments specifically designed for multiple myeloma, psoriasis, fibromyalgia, post-traumatic stress disorder (PTSD), migraine, sexual function and skin disorders. It also provides consulting services to governmental and private entities to assist them with developing and implementing tailor-made medical cannabis program.

Executives

Asher Zwebner director, officer: CHIEF FINANCIAL OFFICER CDOOR CORPORATION, 20 A REHOV SHAREI TORAH BAYIT VEGAN, JERUSALEM L3 96387

OWC Pharmaceutical Research (OWC Pharmaceutical Research) Headlines

From GuruFocus

OWC Pharmaceutical Research Corp, Letter to Shareholders
By PRNewswire PRNewswire • 02-11-2019

OWC Pharmaceutical Research Corp. to Report Progress on Ointment Care for Skin Diseases
By PRNewswire PRNewswire • 12-31-2018

OWC Israel's Patent for Cannabis Based Extracts and Topical Formulations for Use in Skin Disorders, Is Allowed for Issuance as a Patent in the USA
By PRNewswire PRNewswire • 12-16-2019

OWC Pharmaceutical Research Corp Completes Development of Next Generation Orally-Disintegrating Tablet
By PRNewswire PRNewswire • 06-13-2018

OWC Pharmaceutical Research Corp Letter to Shareholders
By PRNewswire PRNewswire • 07-24-2018

OWC Pharmaceutical Research Corp. to Meet With Investors, Researchers and Business Partners at 2018 MJBizCon; Revealing the Testing of Novel Formulation for Multiple Myeloma Therapy
By PRNewswire PRNewswire • 11-06-2018

OWC Pharmaceutical Research Corp. Letter to Shareholders for Upcoming Proxy Voting
By PRNewswire PRNewswire • 08-19-2020

OWC Pharmaceutical Research Corp Reports Progress in Clinical Trials for Ointment Care for Skin Diseases
By PRNewswire PRNewswire • 11-29-2018

OWC Pharmaceutical Research Corp. Reports the Successful Production of Its Cannabinoid-Enriched Sublingual Disintegrating Tablet
By PRNewswire PRNewswire • 12-18-2018

OWC Pharmaceutical Research Corp Raises $5 Million in Preferred Stock Sale to Institutional Investor
By PRNewswire PRNewswire • 05-03-2018